CITIUS PHARMACEUTICALS
Citius Pharmaceuticals is a specialty pharmaceutical company dedicated to the development and commercialization of therapeutic products for large and growing markets. Citius products offer new and expanded indications for previously approved pharmaceutical products as a means to achieve leading market position or market exclusivity. By using previously approved drugs with substantial safety and efficacy data, Citius seeks to reduce the risks associated with pharmaceutical product development. Citius is currently advancing two proprietary product candidates, our Mino-Lokโข product and a Hydrocortisone-Lidocaine formulation. Citius believes the markets for its products are large and underserved by the current standard of care.
CITIUS PHARMACEUTICALS
Industry:
Biotechnology Life Science Medical Therapeutics
Founded:
2007-01-01
Address:
Cranford, New Jersey, United States
Country:
United States
Website Url:
http://www.citiuspharma.com
Total Employee:
11+
Status:
Active
Contact:
(908)967-6677
Email Addresses:
[email protected]
Total Funding:
144.9 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Google Tag Manager Content Delivery Network Google Universal Analytics Domain Not Resolving
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization.
FORMA Therapeutics
FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.
immatics biotechnologies
immatics is a biopharmaceutical company focused on the development of immunotherapeutic substances for cancer therapy.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2016-04-04 | Leonard-Meron Biosciences | Leonard-Meron Biosciences acquired by Citius Pharmaceuticals | N/A |
Investors List
Leonard Mazur
Leonard Mazur investment in Post-IPO Equity - Citius Pharmaceuticals
Myron Holubiak
Myron Holubiak investment in Post-IPO Equity - Citius Pharmaceuticals
Key Employee Changes
| Date | New article |
|---|---|
| 2021-11-05 | Citius Pharmaceuticals Expands Management Team with Appointment of Kelly Creighton, PhD as Executive Vice President of Chemistry, Manufacturing and Controls |
Official Site Inspections
http://www.citiuspharma.com Semrush global rank: 2.51 M Semrush visits lastest month: 7.02 K
Unable to get host informations!!!
More informations about "Citius Pharmaceuticals"
Citius Pharmaceuticals, Inc. | LinkedIn
Citius Pharmaceuticals, Inc. (Nasdaq: CTXR) is a late-stage biopharmaceutical company focused on the development and commercialization of first-in-class critical care products, with a โฆSee details»
Citius Pharmaceuticals - Crunchbase Company Profile & Funding
Organization. Citius Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Citius Pharmaceuticals is a โฆSee details»
Citius Pharmaceuticals (CTXR) Company Profile & Description
Jun 2, 2025 Citius Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of critical care products. Its LYMPHIR, an FDA approved โฆSee details»
Citius Pharma - Overview, News & Similar companies - ZoomInfo
Citius Pharma contact info: Phone number: (908) 967-6677 Website: www.citiuspharma.com What does Citius Pharma do? Citius is a late-stage biopharmaceutical company dedicated to โฆSee details»
Citius Pharma Company Profile | Management and Employees List
[email protected]: Citius Pharma Top Competitors. Company Employees Revenue Top technologies; Urigen. 13: $7.2 M: Nanocopoeia. 20: $4 M: Merrion Pharmaceuticals. n/a: $750 โฆSee details»
Citius Pharmaceuticals, Inc. Company Profile | Cranford, NJ ...
Find company research, competitor information, contact details & financial data for Citius Pharmaceuticals, Inc. of Cranford, NJ. Get the latest business insights from Dun & Bradstreet.See details»
Citius Pharmaceuticals, Inc. (Citius Pharmaceuticals, Inc.) - ่ฏ็ฉ็ฎก โฆ
May 7, 2025 Investor Contact: Ilanit Allen [email protected] 908-967-6677 x113 Media Contact: STiR-communications Greg Salsburg [email protected] -- Financial โฆSee details»
Citius Oncology - Citius Pharmaceuticals Announces $3 Million ...
Nov 15, 2024 Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius Pharma" or the "Company"), a biopharmaceutical company dedicated to the development and commercialization of first-in โฆSee details»
Citius Pharmaceuticals Details Near-Term Milestones for Late โฆ
Jul 10, 2024 National Sales Director onboarded to recruit and lead the sales organization in preparation for anticipated launch of LYMPHIR; CRANFORD, ... Ilanit Allen โฆSee details»
Citius Pharmaceuticals - VentureRadar
"Citius is a late-stage specialty pharmaceutical company dedicated to the development and commercialization of critical care products, with a focus on anti-infectives and cancer care.See details»
Citius Pharmaceuticals, Inc. - About - Overview
Contact Us. Citius Pharmaceuticals, Inc. 11 Commerce Drive, First Floor Cranford, NJ 07016 908-967-6677 [email protected]. follow us on twitterSee details»
Citius Pharmaceuticals
Mar 26, 2025 Citius Pharmaceuticals was founded in 2011 to develop innovative medicines to improve patientโs health and quality of life. Since then, Citius has consistently focused on โฆSee details»
Citius Pharma - News, Mergers and Acquisitions, Locations and
Usearch identified 2 signals for Citius Pharma, including: 2 Mergers and Acquisitions. Usearch discovered 1 location for Citius Pharma including locations in Cranford · New Jersey. Citius โฆSee details»
Citius Pharmaceuticals, Inc. - Investors - Financials & SEC Filings ...
[email protected]. follow us on twitter; follow us on linkedin; Quick Links. SEC Filings; Investor FAQs; Information Request Form; Investor Email Alerts. To opt-in for investor email โฆSee details»
Citius Pharmaceuticals Reports Productive FDA Type C Meeting
Nov 25, 2024 Ilanit Allen [email protected] 908-967-6677 x113. Media Contact: STiR-communications Greg Salsburg [email protected] ...See details»
Citius Pharmaceuticals, Inc. - About
Contact Us. Citius Pharmaceuticals, Inc. 11 Commerce Drive, First Floor Cranford, NJ 07016 908-967-6677 [email protected]. follow us on twitterSee details»
Citius Pharmaceuticals, Inc. - About - Board of Directors - Person โฆ
Contact Us. Citius Pharmaceuticals, Inc. 11 Commerce Drive, First Floor Cranford, NJ 07016 908-967-6677 [email protected]. follow us on twitterSee details»
About - Board of Directors - Person Details - Citius Pharma
Contact Us. Citius Pharmaceuticals, Inc. 11 Commerce Drive, First Floor Cranford, NJ 07016 908-967-6677 [email protected]. follow us on twitterSee details»
Citius Oncology Enters into Distribution Services Agreement with ...
10 hours ago Citius Oncology, Inc. ("Citius Oncology") (Nasdaq: CTOR), the oncology-focused subsidiary of Citius Pharmaceuticals, Inc. ("Citius Pharma") (Nasdaq: CTXR), a late-stage โฆSee details»
Citius Pharmaceuticals, Inc. - Investors - Investment Highlights
Contact Us. Citius Pharmaceuticals, Inc. 11 Commerce Drive, First Floor Cranford, NJ 07016 908-967-6677 [email protected]. follow us on twitterSee details»